• N/A
    Market Cap
  • -97.48%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Income Statement
Total Operating Revenue
1.9M
+11,414.54%
16,468
-66.73%
49,501
+83.13%
27,031
N/A
Cost of Revenue
660,024
+478.26%
114,140
+245.17%
33,068
+72.70%
19,148
N/A
Gross Profit
1.2M
+1,365.66%
-97,672
-694.36%
16,433
+108.46%
7,883
N/A
Sales and Marketing Expense
N/A
N/A
23,772
-93.72%
378,706
-38.11%
611,914
+8,225.36%
Research and Development Expense
-61,875
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
17,136
+94.57%
8,807
+13.81%
7,738
+64.25%
4,711
N/A
Total Operating Expenses
2.9M
+872.91%
301,551
-78.55%
1.4M
-44.64%
2.5M
+39.99%
Operating Profit
-1.7M
+325.23%
-399,223
-71.27%
-1.4M
-45.11%
-2.5M
+39.55%
Interest Income
69,243
+157.70%
-120,000
N/A
N/A
N/A
690
+102.76%
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
69,243
+157.70%
-120,000
N/A
0
-100.00%
690
+100.87%
Total Nonoperating Income and Expense
-435,582
-57.16%
-1.0M
-149.77%
2.0M
+187.25%
-2.3M
+1,536.23%
Income before Taxes
-1.7M
+325.23%
-399,223
-71.27%
-1.4M
-45.11%
-2.5M
+39.55%
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-2.1M
+50.65%
-1.4M
-316.63%
653,627
+113.41%
-4.9M
+151.02%
Net Income from Continuing Operations Applicable to Common
-2.1M
+50.65%
-1.4M
-316.63%
653,627
+113.41%
-4.9M
-349.00%
Basic EPS and Net Income
-0.02
0.00%
-0.02
-300.00%
0.01
+105.26%
-0.19
+90.00%
Diluted EPS and Net Income
-0.02
0.00%
-0.02
-300.00%
0.01
+105.26%
-0.19
+90.00%
Basic Weighted Average Shares
98.1M
+22.60%
80.0M
+6.07%
75.4M
+142.68%
31.1M
+22.12%
Diluted Weighted Average Shares
98.1M
+22.60%
80.0M
+6.07%
75.4M
+142.68%
31.1M
+22.12%
Balance Sheet
Cash and Cash Equivalents
8,048
+16.00%
6,938
-89.23%
64,419
+398.87%
12,913
-88.71%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
8,048
+16.00%
6,938
-89.23%
64,419
+398.87%
12,913
-88.71%
Total Current Assets
1.0M
+5.82%
976,938
+160.58%
374,911
+39.10%
269,519
+59.55%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
15,303
0.00%
15,303
-36.53%
24,110
-23.06%
31,337
N/A
Total Long-Term Assets
805,379
+5,162.88%
15,303
-36.53%
24,110
-23.06%
31,337
N/A
Total Assets
1.9M
+86.88%
992,341
+148.63%
399,121
+32.62%
300,956
+78.06%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
3.0M
+63.19%
1.8M
+59.98%
1.2M
-39.59%
1.9M
+175.89%
Total Current Liabilities
5.1M
+61.58%
3.1M
+102.34%
1.5M
-64.89%
4.4M
+277.81%
Total Long-Term Debt
2.0M
-4.63%
2.0M
+72.08%
1.2M
-36.26%
1.9M
+215.78%
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Liabilities
5.1M
+61.58%
3.1M
+102.34%
1.5M
-64.89%
4.4M
+277.81%
Retained Earnings
-28.9M
+7.98%
-26.7M
+5.59%
-25.3M
-2.52%
-26.0M
+23.09%
Total Stockholders Equity
N/A
N/A
-2.1M
+86.23%
-1.1M
-72.04%
-4.1M
+311.70%
Total Shares Outstanding
110.4M
+27.45%
86.6M
+14.83%
75.4M
+67.47%
45.0M
+65.04%
Cash Flow
Cash from Operating Activities
-1.0M
-9,316.03%
11,166
+100.78%
-1.4M
-48.66%
-2.8M
+101.46%
Capital Expenditures
1,000
0.00%
1,000
0.00%
1,000
-97.23%
36,048
+3,504.80%
Cash from Investing Activities
-358,261
-55.50%
-805,000
N/A
N/A
N/A
-36,048
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
1.4M
+88.56%
736,353
-50.25%
1.5M
-45.52%
2.7M
+82.06%
Financials Ratio
Gross Margin
65.19%
+110.99%
-593.10%
-1,886.60%
33.20%
+13.83%
29.16%
N/A
Operating Margin
-89.53%
-96.31%
-2,424.23%
-13.63%
-2,806.80%
-70.03%
-9,364.82%
N/A
Return on Assets
-149.87%
-26.36%
-203.52%
-208.99%
186.73%
+109.00%
-2,073.73%
+60.11%
Return on Equity
N/A
N/A
86.28%
+446.42%
-24.91%
-113.03%
191.17%
-22.03%
Revenue Growth
11,414.54%
+17,205.05%
-66.73%
-180.28%
83.13%
N/A
N/A
N/A
Current Ratio
0.20
-34.52%
0.31
+28.78%
0.24
+296.24%
0.06
-57.79%
Cash Ratio
0.002
-27.27%
0.002
-94.72%
0.04
+1,337.93%
0.003
-97.04%
Debt-to-Equity Ratio
N/A
N/A
-1.82
-10.80%
-2.04
+121.97%
-0.92
-28.53%
Debt-to-Assets Ratio
2.68
-31.75%
3.92
-33.19%
5.87
-53.21%
12.54
+65.26%

Earnings & Revenue History

Debt-to-Assets

Cash Flow